Tus-Pharmaceutical Group Co., Ltd. (000590.SZ)

CNY 7.9

(-1.5%)

EBITDA Summary of Tus-Pharmaceutical Group Co., Ltd.

  • Tus-Pharmaceutical Group Co., Ltd.'s latest annual EBITDA in 2023 was 62.18 Million CNY , down -27.17% from previous year.
  • Tus-Pharmaceutical Group Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was -4.15 Million CNY , up 67.14% from previous quarter.
  • Tus-Pharmaceutical Group Co., Ltd. reported an annual EBITDA of 48.43 Million CNY in 2022, down -25.11% from previous year.
  • Tus-Pharmaceutical Group Co., Ltd. reported an annual EBITDA of 62.46 Million CNY in 2021, up 44.05% from previous year.
  • Tus-Pharmaceutical Group Co., Ltd. reported a quarterly EBITDA of -11.93 Million CNY for 2024 Q2, down -4383.92% from previous quarter.
  • Tus-Pharmaceutical Group Co., Ltd. reported a quarterly EBITDA of -4.15 Million CNY for 2024 Q3, up 67.14% from previous quarter.

Annual EBITDA Chart of Tus-Pharmaceutical Group Co., Ltd. (2023 - 1992)

Historical Annual EBITDA of Tus-Pharmaceutical Group Co., Ltd. (2023 - 1992)

Year EBITDA EBITDA Growth
2023 62.18 Million CNY -27.17%
2022 48.43 Million CNY -25.11%
2021 62.46 Million CNY 44.05%
2020 42.42 Million CNY -13.43%
2019 70.91 Million CNY 565.33%
2018 -16.69 Million CNY -127.89%
2017 38.17 Million CNY -57.07%
2016 84.75 Million CNY 61.74%
2015 49.14 Million CNY 200.28%
2014 -70.84 Million CNY 28.38%
2013 -147.9 Million CNY -141.69%
2012 204.84 Million CNY 43.51%
2011 108.16 Million CNY 55.66%
2010 77.73 Million CNY 97.85%
2009 -51.68 Million CNY -32.83%
2008 53.5 Million CNY -2.87%
2007 64.93 Million CNY 38.14%
2006 47 Million CNY 3.32%
2005 45.49 Million CNY 0.06%
2004 45.47 Million CNY 380.6%
2003 9.46 Million CNY -71.38%
2002 33.02 Million CNY 184.03%
2001 -39.33 Million CNY -172.7%
2000 38.39 Million CNY 63.5%
1999 33.06 Million CNY -16.37%
1998 37.29 Million CNY 33.73%
1997 29.59 Million CNY 96.77%
1996 15.04 Million CNY -29.37%
1995 21.29 Million CNY 21.08%
1994 17.58 Million CNY 61.67%
1993 10.87 Million CNY 174.65%
1992 3.96 Million CNY 0.0%

Peer EBITDA Comparison of Tus-Pharmaceutical Group Co., Ltd.

Name EBITDA EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd. -141.51 Million CNY 143.942%
Anhui Fengyuan Pharmaceutical Co., Ltd. 388.66 Million CNY 84.001%
Dong-E-E-Jiao Co.,Ltd. 1.53 Billion CNY 95.961%
Livzon Pharmaceutical Group Inc. 3.29 Billion CNY 98.114%
Hainan Haiyao Co., Ltd. 152.19 Million CNY 59.143%
Jilin Aodong Pharmaceutical Group Co., Ltd. 1.87 Billion CNY 96.69%
Changchun High-Tech Industries (Group) Inc. 6.09 Billion CNY 98.98%
Apeloa Pharmaceutical Co.,Ltd 1.79 Billion CNY 96.53%
PKU HealthCare Corp.,Ltd. 132.39 Million CNY 53.031%
Chengdu Huasun Technology Group Inc., Ltd. 74.04 Million CNY 16.02%
Dezhan Healthcare Company Limited 219.36 Million CNY 71.653%
Jinling Pharmaceutical Company Limited 249.63 Million CNY 75.09%
Jiuzhitang Co., Ltd. 460.28 Million CNY 86.49%
Huapont Life Sciences Co., Ltd. 2.12 Billion CNY 97.077%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 945.42 Million CNY 93.423%
Shandong Wohua Pharmaceutical Co., Ltd. 87.98 Million CNY 29.329%
Hengkang Medical Group Co., Ltd. 348.09 Million CNY 82.136%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 453.78 Million CNY 86.297%
Qianjiang Yongan Pharmaceutical Co., Ltd. 141.6 Million CNY 56.088%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 124.71 Million CNY 50.142%
Jinhe Biotechnology CO., LTD. 345.42 Million CNY 81.998%
Teyi Pharmaceutical Group Co.,Ltd 369.46 Million CNY 83.169%
Kunming Longjin Pharmaceutical Co., Ltd. -31.19 Million CNY 299.319%
Beijing Aosaikang Pharmaceutical Co., Ltd. -112.74 Million CNY 155.153%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 1.38 Billion CNY 95.522%
Anhui Huangshan Capsule Co., Ltd. 118.18 Million CNY 47.386%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 166.4 Million CNY 62.632%
Zhuhai Rundu Pharmaceutical Co., Ltd. 215.02 Million CNY 71.081%
Huaren Pharmaceutical Co., Ltd. 431.65 Million CNY 85.594%
Tianjin Ringpu Bio-Technology Co.,Ltd. 711.43 Million CNY 91.259%
Shanxi Zhendong Pharmaceutical Co.,Ltd 94.75 Million CNY 34.374%
Fuan Pharmaceutical (Group) Co., Ltd. 528.99 Million CNY 88.245%
Hybio Pharmaceutical Co., Ltd. -233.61 Million CNY 126.618%
Baotou Dongbao Bio-Tech Co.,Ltd 236.24 Million CNY 73.679%
Hunan Er-Kang Pharmaceutical Co., Ltd 12.02 Million CNY -417.224%
Changjiang Pharmaceutical Group Co., Ltd. -572.69 Million CNY 110.858%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 383.11 Million CNY 83.769%
Fujian Cosunter Pharmaceutical Co., Ltd. -190.85 Million CNY 132.581%
Beijing Science Sun Pharmaceutical Co., Ltd. 7.7 Million CNY -707.253%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 87.94 Million CNY 29.297%
Hainan Poly Pharm. Co., Ltd 309.33 Million CNY 79.898%
Jiangxi Synergy Pharmaceutical Co., Ltd. 192.54 Million CNY 67.704%
Wuhan Hiteck Biological Pharma Co.,Ltd -73.65 Million CNY 184.422%
Shandong Xinhua Pharmaceutical Company Limited 1.09 Billion CNY 94.324%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 435.22 Million CNY 85.713%
PharmaBlock Sciences (Nanjing), Inc. 380.8 Million CNY 83.671%
Jinghua Pharmaceutical Group Co., Ltd. 417.61 Million CNY 85.11%
Zhejiang Hisoar Pharmaceutical Co., Ltd. -43.99 Million CNY 241.344%
Betta Pharmaceuticals Co., Ltd. 696.09 Million CNY 91.067%
Tibet AIM Pharm. Inc. 50.76 Million CNY -22.499%
Shenzhen Kangtai Biological Products Co., Ltd. 1.29 Billion CNY 95.199%
Shandong Shanda Wit Science and Technology Co., Ltd. 1.39 Billion CNY 95.555%
Pacific Shuanglin Bio-pharmacy Co., LTD 841.98 Million CNY 92.615%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 300.14 Million CNY 79.282%
Xiamen Kingdomway Group Company 588.78 Million CNY 89.439%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 127.06 Million CNY 51.062%
Walvax Biotechnology Co., Ltd. 938.22 Million CNY 93.372%
Sunflower Pharmaceutical Group Co.,Ltd 1.54 Billion CNY 95.98%
Harbin Gloria Pharmaceuticals Co., Ltd 275.28 Million CNY 77.411%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 4.68 Billion CNY 98.674%
Hunan Hansen Pharmaceutical Co., Ltd. 280.66 Million CNY 77.844%
Changzhou Qianhong Biopharma CO.,LTD 278.66 Million CNY 77.686%
Shenzhen Weiguang Biological Products Co., Ltd. 350.21 Million CNY 82.244%
Honz Pharmaceutical Co., Ltd. 133.53 Million CNY 53.432%
Northeast Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 94.803%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 217.47 Million CNY 71.407%
Guizhou Xinbang Pharmaceutical Co., Ltd. 654.01 Million CNY 90.492%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 477.37 Million CNY 86.974%
Zhejiang Yatai Pharmaceutical Co., Ltd. 76.31 Million CNY 18.516%
Zhejiang NHU Company Ltd. 5.24 Billion CNY 98.815%
ApicHope Pharmaceutical Co., Ltd 464.04 Million CNY 86.6%
Shanghai Kaibao Pharmaceutical CO.,Ltd 375.33 Million CNY 83.433%
Beijing SL Pharmaceutical Co., Ltd. 610.29 Million CNY 89.811%
Yunnan Baiyao Group Co.,Ltd 5.2 Billion CNY 98.806%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 127.72 Million CNY 51.313%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 228.9 Million CNY 72.834%
Guangdong Lifestrong Pharmacy Co., Ltd. 50.95 Million CNY -22.023%
Huadong Medicine Co., Ltd 4.61 Billion CNY 98.653%
Jiangsu Nhwa Pharmaceutical Co., LTD 1.33 Billion CNY 95.356%
Harbin Medisan Pharmaceutical Co., Ltd. 183.66 Million CNY 66.143%
LanZhou Foci Pharmaceutical Co.,Ltd. 135.36 Million CNY 54.064%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 1.04 Billion CNY 94.061%
Beijing Beilu Pharmaceutical Co., Ltd 36.44 Million CNY -70.619%
Nanjing Hicin Pharmaceutical Co., Ltd. 97 Million CNY 35.895%
Renhe Pharmacy Co., Ltd. 1.05 Billion CNY 94.082%
Chongqing Pharscin Pharmaceutical Co., Ltd. 125.84 Million CNY 50.589%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 863.95 Million CNY 92.803%
Luoxin Pharmaceuticals Group Stock Co., Ltd. -320.08 Million CNY 119.427%
Guizhou Bailing Group Pharmaceutical Co., Ltd. -298.6 Million CNY 120.824%